Lynne M Mofenson

Lynne M Mofenson

UNVERIFIED PROFILE

Are you Lynne M Mofenson?   Register this Author

Register author
Lynne M Mofenson

Lynne M Mofenson

Publications by authors named "Lynne M Mofenson"

Are you Lynne M Mofenson?   Register this Author

100Publications

2385Reads

46Profile Views

Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy.

Clin Infect Dis 2019 Oct 9. Epub 2019 Oct 9.

Liverpool School of Tropical Medicine, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz684DOI Listing
October 2019

Decision Making in a Time of Uncertainty: Dolutegravir for Reproductive-Age Women.

Ann Intern Med 2019 05 2;170(9):658-659. Epub 2019 Apr 2.

Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M19-0641DOI Listing
May 2019

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum.

J Clin Pharmacol 2019 03 25;59(3):386-393. Epub 2018 Oct 25.

Division of Maternal Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368469PMC
March 2019

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.

BMC Pregnancy Childbirth 2019 Feb 27;19(1):81. Epub 2019 Feb 27.

Division of Global Women's Health, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, 3009 Old Clinic Building, Campus Box 7577, Chapel Hill, NC, 27599-7577, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12884-019-2224-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391830PMC
February 2019

Reply to Kojima and Klausner.

Clin Infect Dis 2018 10;67(9):1469-1470

Division of Infectious Diseases, University of Pittsburgh, School of Medicine, Pennyslvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186858PMC
October 2018

In-utero ART exposure and the need for pharmacovigilance.

Authors:
Lynne M Mofenson

Lancet Glob Health 2018 07 4;6(7):e716-e717. Epub 2018 Jun 4.

Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC 20036, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2214-109X(18)30272-9DOI Listing
July 2018

Risk of HIV Acquisition During Pregnancy and Postpartum: A Call for Action.

Authors:
Lynne M Mofenson

J Infect Dis 2018 06;218(1):1-4

Elizabeth Glaser Pediatric AIDS Foundation, Washington DC.

View Article

Download full-text PDF

Source
https://academic.oup.com/jid/article/218/1/1/4913312
Publisher Site
http://dx.doi.org/10.1093/infdis/jiy118DOI Listing
June 2018

Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.

J Acquir Immune Defic Syndr 2017 Sep;76(1):1-12

*Departments of Epidemiology, Microbiology and Infectious Diseases, University of Pittsburgh, Pittsburgh, PA; †Department of Medicine, Centre for Infectious Diseases, Stellenbosch University, Cape Town, South Africa; ‡Departments of Epidemiology and International Health, Johns Hopkins University, Baltimore, MD; §Centre for Applied Health Research & Delivery, Warwick Medical School, The University of Warwick, Coventry, United Kingdom; ‖Department of Public Health (IHCAR), Karolinska Institute, Stockholm, Sweden; ¶Department of Global Health, Centre for Evidence-Based Health Care, Stellenbosch University, Tygerberg, South Africa; #Elizabeth Glazer Pediatric AIDS Foundation, Washington, DC; **Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD; ††Department of Statistics, University of British Columbia, Vancouver, Canada; ‡‡Global Evaluative Science, Vancouver, Canada; and §§Department of HIV, World Health Organization, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553236PMC
September 2017

Preventing Human Immunodeficiency Virus Acquisition in Youth-Generations at Risk.

Authors:
Lynne M Mofenson

JAMA Pediatr 2017 09;171(9):829-830

Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamapediatrics.2017.1702DOI Listing
September 2017

Youth engagement in developing an implementation science research agenda on adolescent HIV testing and care linkages in sub-Saharan Africa.

AIDS 2017 Jul;31 Suppl 3:S195-S201

aJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland bUniversity of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina cElizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia dUnited Nations Children's Fund, New York, New York, USA eThe Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa fThe Population Council, Washington DC gYouth Advocate, Zambia and Youth Advocate, Botswana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497774PMC
July 2017

Preconception ART and preterm birth: real effect or selection bias? - Authors' reply.

Lancet HIV 2017 04;4(4):e150-e151

Elizabeth Glazer Pediatric AIDS Foundation, Washington DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(17)30051-6DOI Listing
April 2017

Antiretroviral Therapy for Perinatal HIV Prevention.

N Engl J Med 2017 02;376(7):699-700

Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1616287DOI Listing
February 2017

Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.

AIDS 2017 01;31(2):213-232

aElizabeth Glaser Pediatric AIDS Foundation, Washington DC, USA bWorld Health Organization, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001313DOI Listing
January 2017

Diagnosis of HIV Infection During Early Infancy: How Early Is Early Enough?

Authors:
Lynne M Mofenson

J Infect Dis 2016 11 17;214(9):1294-1296. Epub 2016 Aug 17.

Elizabeth Glaser Pediatric AIDS Foundation, Washington D.C.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw383DOI Listing
November 2016

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

N Engl J Med 2016 11;375(18):1726-1737

From the Department of Pathology, Johns Hopkins University School of Medicine (M.G.F.), and the Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health (T.E.T.), Baltimore, and the Division of AIDS, National Institute of Allergy and Infectious Diseases (D.G., K.L.K., R. Browning, L.P.), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (G.K.S.), National Institutes of Health, Bethesda - all in Maryland; the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston (M.Q., T.F., D.E.S.); the Retrovirology Core Laboratory, University of North Carolina School of Medicine, Chapel Hill (S.A.F., A.J.L.), and FHI 360, Durham (A.S.C.) - both in North Carolina; the UCLA Center for Clinical AIDS Research and Education, Los Angeles (J.S.C.); St. Jude Children's Research Hospital, Memphis, TN (P.M.F.); the Department of Obstetrics and Gynecology, College of Health Sciences, University of Zimbabwe, Harare (T.C.); Anova Health Institute (J.M.), Perinatal HIV Research Unit, University of the Witwatersrand, Faculty of Health Sciences (A.V.), and Empilweni Services and Research Unit (R.S.), Johannesburg, School of Public Health and Family Medicine, University of Cape Town (J.M.), and the Department of Obstetrics and Gynaecology, Stellenbosch University (G.B.T.), Cape Town, and the Centre for the AIDS Programme of Research in South Africa-Umlazi Clinical Research Site (D.M.) and Durban Paediatric HIV (R. Bobat), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban - all in South Africa; the University of North Carolina Project, Kamuzu Central Hospital-Tidziwe Center, Lilongwe, Malawi (F.E.M.); Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda (M.O.); the Department of Obstetrics and Gynecology, B.J. Medical College, Pune, India (R. Bhosale); the Centre for Infectious Disease Research in Zambia, Lusaka, Zambia (B.H.C.); Kilimanjaro Christian Medical Center-Duke University Collaboration, Moshi, Tanzania (P.M.); Frontier Science and Technology Research Foundation, Amherst, NY (M.B.); and the Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1511691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214343PMC
November 2016

Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.

Authors:
Lynne M Mofenson

PLoS Med 2016 Sep 27;13(9):e1002133. Epub 2016 Sep 27.

Elizabeth Glaser Pediatric AIDS Foundation, Washington, D.C., United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pmed.1002133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038968PMC
September 2016

Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.

Pediatr Infect Dis J 2016 Aug;35(8):894-900

From the *David Geffen UCLA School of Medicine, Los Angeles, California; †UCLA Fielding School of Public Health, Department of Epidemiology, Los Angeles, California; ‡Westat, Rockville, Maryland; §Fundacao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil; ¶Office of the Global AIDS Coordinator, US Department of State, Washington DC; ‖Cepheid, Sunnyvale, California; **Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; ††Hospital Geral de Nova Iguaçu, DST/AIDS, Nova Iguaçu, Rio de Janeiro, Brazil; ‡‡Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil; §§SAMRC and Perinatal HIV Research Unit, University of Witwatersrand, Cape Town, South Africa; ¶¶Department of Obstetrics and Gynecology, Stellenbosch University/Tygerberg Hospital, Cape Town, South Africa; ‖‖Serviço de Infectologia, Hospital Conceicao, Porto Alegre, Rio Grande do Sul, Brazil; ***Hospital Femina, Porto Alegre, Rio Grande do Sul, Brazil; †††Irmandade da Santa Casa de Misericordia de Porto Alegre, Rio Grande do Sul, Brazil; ‡‡‡Department of Pediatrics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; §§§Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil; ¶¶¶Foundation for Maternal and Infant Health (FUNDASAMIN), Buenos Aires, Argentina; and ‖‖‖Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000001199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945428PMC
August 2016

Eliminating Pediatric HIV-1 Infection.

N Engl J Med 2016 07;375(2):193-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1604016DOI Listing
July 2016

Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?

Authors:
Lynne M Mofenson

J Infect Dis 2016 Apr 10;213(7):1051-4. Epub 2015 Aug 10.

Elizabeth Glaser Pediatric AIDS Foundation, Washington D.C.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv390DOI Listing
April 2016

Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.

Matern Child Health J 2016 Mar;20(3):542-9

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, E7139, Baltimore, MD, 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10995-015-1852-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754130PMC
March 2016

Challenges in the Elimination of Pediatric HIV-1 Infection.

N Engl J Med 2016 Feb;374(8):761-70

From the Program in Molecular Medicine, University of Massachusetts Medical School, Worcester (K.L.); and the Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC (L.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMra1505256DOI Listing
February 2016

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Pediatr Infect Dis J 2015 Dec;34(12):1361-4

From the *Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; †HIV/AIDS Department, World Health Organization, Geneva, Switzerland; ‡Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa; §Kheth'Impilo, Cape Town, South Africa; ¶Médecins Sans Frontières, Khayelitsha, South Africa; ‖McCord Hospital, Durban, South Africa; **Hlabisa HIV Program, South Africa; ††Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, University of the Witwatersrand, Johannesburg, South Africa; ‡‡Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa; §§Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; ¶¶Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; ‖‖Gugulethu HIV Program, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; ***Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, Maryland; and †††Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384719PMC
December 2015

Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission.

Sex Transm Dis 2015 Oct;42(10):554-65

From the *David Geffen UCLA School of Medicine, Los Angeles, CA; †Fielding School of Public Health, UCLA, Los Angeles, CA; ‡Westat, Rockville, MD; §Fundacao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil; ¶Office of the Global AIDS Coordinator, US Department of State, Washington, DC; ∥Cepheid, Sunnyvale, CA; **Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; ††Hospital Geral de Nova Iguaçu, Nova Iguaçu, RJ, Brazil; and ‡‡Hospital Federal dos Servidores do Estado, Rio de Janeiro, RJ, Brazil.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/stdjournal/2015/10000/Chlamydia
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/OLQ.0000000000000340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571193PMC
October 2015

Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.

J Acquir Immune Defic Syndr 2015 Sep;70(1):33-41

*Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Southern California School of Medicine, Los Angeles, CA; †Department of Biostatistics, Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA; ‡Department of Medicine, Children's Hospital Boston, Boston, MA; §HIV/AIDS Research Department, Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil; ‖Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; ¶Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; #Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, DHHS, Bethesda, MD; **National Institute of Allergy and Infectious Diseases, Bethesda, MD; and ††Department of Pediatrics, Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579345PMC
September 2015

Editorial commentary: New challenges in the elimination of pediatric HIV infection: the expanding population of HIV-exposed but uninfected children.

Authors:
Lynne M Mofenson

Clin Infect Dis 2015 May 2;60(9):1357-60. Epub 2015 Feb 2.

Elizabeth Glaser Pediatric AIDS Foundation, Washington, D.C.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/civ064DOI Listing
May 2015

Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study.

Pediatr Infect Dis J 2015 Mar;34(3):e52-7

From the *David Geffen UCLA School of Medicine, Los Angeles, CA; †Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; ‡Westat, Rockville, MD; §Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil; ¶Hospital Geral de Nova Iguaçu, Nova Iguaçu and Laboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, (Fiocruz), Rio de Janeiro, Brazil; ‖Perinatal HIV Research Unit, University of Witwatersrand/Chris Hani Baragwanath Hospital, Johannesburg, South Africa; **Stellenbosch University/Tygerberg Hospital, Cape Town, South Africa; ††Hospital Conceicao, Porto Alegre, RS, Brazil; ‡‡Hospital Femina, Porto Alegre, RS, Brazil; §§Irmandade da Santa Casa de Misericordia de Porto Alegre, RS, Brazil; ¶¶Federal University of Minas Gerais, Belo Horizonte, MG, Brazil; ‖‖Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil; ***Foundation for Maternal and Infant Health (FUNDASAMIN), Buenos Aires, Argentina; †††Escola Paulista de Medicine-Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil; and ‡‡‡Laboratório de Pesquisa Clínica em DST e AIDS - Instituto de Pesquisa Clínica Evandro Chagas - Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352722PMC
March 2015

Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.

Pediatr Infect Dis J 2015 Feb;34(2):162-7

From the *Children's Hospital of Philadelphia, Philadelphia, PA; †Harvard School of Public Health, Boston, MA; ‡University of Nebraska Medical Center, Omaha, NE; §University of Colorado Health Sciences Center, Aurora, CO; ¶Division of AIDS, NIAID, NIH, Bethesda, MD; ‖Maternal and Pediatric Infectious Disease Branch, NICHD, NIH, Bethesda, MD; **Frontier Science Technology Research Foundation, Amherst, NY; ††Bristol-Myers Squibb, Wallingford, CT; and ‡‡Children's Hospital of Los Angeles, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355059PMC
February 2015

Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.

AIDS 2015 Jan;29(1):91-100

aWayne State University School of Medicine and Children's Hospital of Michigan, Detroit, Michigan bUniversity of Miami Leonard M Miller School of Medicine, Miami, Florida cCenter for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts dUniversity of Illinois at Chicago, Chicago, Illinois eTulane University Health Sciences Center, New Orleans, Louisiana fFrontier Science Technology and Research Foundation, Amherst, New York gNational Heart, Lung, and Blood Institute hEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland iBaylor College of Medicine and Texas Children's Hospital, Houston, Texas jBoston Children's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287991PMC
January 2015

Raltegravir pharmacokinetics in neonates following maternal dosing.

J Acquir Immune Defic Syndr 2014 Nov;67(3):310-5

*Section of Pediatric Infectious Diseases, Boston Medical Center, Boston, MA; †Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, AL; ‡Merck & Co., Inc., Whitehouse Station, NJ; §Department of Pediatric Infectious Diseases, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA; ‖Department of Pediatrics, University of California, San Diego and Rady Children's Hospital San Diego, La Jolla, CA; ¶Eunice Kennedy Shriver National Institute of Child Health and Human Development, #Division of AIDS, National Institute of Health, Bethesda, MD; **Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; ††Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA; and ‡‡Department of Pediatrics, Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197108PMC
November 2014

A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance.

J Acquir Immune Defic Syndr 2014 Nov;67 Suppl 2:S163-7

*Fogarty International Center, National Institutes of Health, Bethesda, MD; †Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC; ‡Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; §Office of the US Global AIDS Coordinator, US Department of State, Washington, DC; ‖Anova Health Institute, Johannesburg, South Africa; ¶National Institute of Mental Health, National Institutes of Health, Bethesda, MD; and #Office of Research on Women's Health, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000323DOI Listing
November 2014

Realization of an AIDS-free generation: ensuring sustainable treatment for children.

JAMA 2014 Jul 23-30;312(4):339-40

The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.5806DOI Listing
August 2014

Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.

Pediatr Infect Dis J 2014 Aug;33(8):846-54

From the *Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA; †University of Witwatersrand, Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Johannesburg, South Africa; ‡Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; §Department of Epidemiology, ICAP, Mailman School of Public Health and College of Physicians and Surgeons, Columbia University, New York, NY; ¶Department of Paediatrics and Child Health, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe; ‖Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda; **University of North Carolina Project, Lilongwe, Malawi; ††University Teaching Hospital, Lusaka, Zambia; ‡‡Division of Paediatrics and Infectious Diseases, Tygerberg Children's Hospital, Stellenbosch University, Tygerberg; §§University of the Witwatersrand Reproductive Health and HIV Institute, Faculty of Health Sciences, Johannesburg, South Africa; ¶¶Department of Pediatrics, BJ Medical College and Sassoon General Hospital, Pune, India; ‖‖Duke University-Kilimanjaro Christian Medical Center Collaboration, Moshi, Tanzania; ***Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa; †††Frontier Science and Technology Research Foundation, Amherst, NY; ‡‡‡Social and Scientific Systems, Durham, NC; §§§Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD; ¶¶¶HJF-DAIDS, a Division of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Contractor to NIAID, NIH, DHHS, Bethesda, MD; and ‖‖‖Division of Infectious Diseases and International Health, Geisel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166566PMC
August 2014

Children born into families affected by HIV.

AIDS 2014 Jul;28 Suppl 3:S241-4

aDST-NRF Centre of Excellence in Human Development, Universities of the Witwatersrand and KwaZulu-Natal, and the Human Sciences Research Council, 750 Francois Road, Cato Manor, Durban 4001, South Africa bEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000361DOI Listing
July 2014

Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.

PLoS Med 2014 Apr 29;11(4):e1001636. Epub 2014 Apr 29.

Office of the Global AIDS Coordinator, US Department of State, Washington (D.C.), United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pmed.1001636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004531PMC
April 2014

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

J Acquir Immune Defic Syndr 2014 Mar;65(3):366-74

*Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; †Maternal Adolescent and Child Health, University of the Witwatersrand, South Africa; ‡Fred Hutchinson Cancer Research Center, Seattle, WA; §Department of Pediatrics, Stanford University School of Medicine, Stanford, CA; ‖Department of Obstetrics and Gynecology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe; ¶Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa; #Makerere University, Johns Hopkins University, Research Collaboration, Kampala, Uganda; **Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; ††Department of Pediatrics, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe; ‡‡Department of Global Health and Population, Harvard University School of Public Health, Boston, MA; §§Family Health International, Research Triangle Park, NC; ‖‖Division of HIV/AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD; and ¶¶Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945386PMC
March 2014

The challenges of success: adolescents with perinatal HIV infection.

J Int AIDS Soc 2013 Jun 18;16:18650. Epub 2013 Jun 18.

Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687076PMC
http://dx.doi.org/10.7448/IAS.16.1.18650DOI Listing
June 2013

Combination antiretroviral use and preterm birth.

J Infect Dis 2013 Feb 29;207(4):612-21. Epub 2012 Nov 29.

Pediatric, Adolescent, and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jis728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549601PMC
February 2013

Antiretrovirals in pregnancy: a note of caution.

J Infect Dis 2012 Dec 12;206(11):1639-41. Epub 2012 Oct 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jis581DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499111PMC
December 2012

Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.

AIDS 2012 Oct;26(16):2039-52

Department of International Health, Global Disease Epidemiology and Control Program, Johns Hopkins University Bloomberg School of Public Health, 615N. Wolfe Street, Suite W5031, Baltimore,MD21205, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061936PMC
http://dx.doi.org/10.1097/QAD.0b013e328359590fDOI Listing
October 2012

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.

AIDS 2012 Jun;26(9):1151-9

Pediatric Adolescent Maternal AIDS Branch, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328352d135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476702PMC
June 2012

Unresolved antiretroviral treatment management issues in HIV-infected children.

J Acquir Immune Defic Syndr 2012 Feb;59(2):161-9

Department of Research Promotion, International AIDS Society, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182427029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825866PMC
February 2012

Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.

Clin Infect Dis 2011 Aug;53(4):388-95

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cir413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202326PMC
August 2011

Antiretroviral drugs to prevent breastfeeding HIV transmission.

Authors:
Lynne M Mofenson

Antivir Ther 2010 ;15(4):537-53

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP1574DOI Listing
October 2010

Protecting the next generation--eliminating perinatal HIV-1 infection.

Authors:
Lynne M Mofenson

N Engl J Med 2010 Jun;362(24):2316-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1004406DOI Listing
June 2010

Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.

Annu Rev Med 2010 ;61:169-85

Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Center for Research for Mothers and Children, National Institutes of Health, Rockville, Maryland 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.med.050108.151127DOI Listing
May 2010

Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection.

Authors:
Lynne M Mofenson

Clin Infect Dis 2010 May;50 Suppl 3:S130-48

Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/651484DOI Listing
May 2010

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Pediatrics 2010 Feb 18;125(2):e250-60. Epub 2010 Jan 18.

Department of Biostatistics, Harvard School of Public Health, 665 Huntington Ave, Building I, 415, Boston, MA 02115-6017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2009-1112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951128PMC
February 2010

Prevention of breast milk transmission of HIV: the time is now.

Authors:
Lynne M Mofenson

J Acquir Immune Defic Syndr 2009 Nov;52(3):305-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3181bbfe14DOI Listing
November 2009